| How sodium arsenite improve amyloid β-induced memory deficit? E Nassireslami, P Nikbin, E Amini, B Payandemehr, F Shaerzadeh, ... Physiology & behavior 163, 97-106, 2016 | 24 | 2016 |
| Paradoxical role of PKA inhibitor on amyloidβ-induced memory deficit E Amini, E Nassireslami, B Payandemehr, F Khodagholi, F Foolad, ... Physiology & behavior 149, 76-85, 2015 | 23 | 2015 |
| Can pharmacokinetic studies assess the pulmonary fate of dry powder inhaler formulations of fluticasone propionate? G Hochhaus, MJ Chen, A Kurumaddali, U Schilling, Y Jiao, SK Drescher, ... The AAPS journal 23, 1-14, 2021 | 21 | 2021 |
| A cAMP analog reverses contextual and tone memory deficits induced by a PKA inhibitor in Pavlovian fear conditioning E Nassireslami, P Nikbin, B Payandemehr, E Amini, M Mohammadi, ... Pharmacology Biochemistry and Behavior 105, 177-182, 2013 | 21 | 2013 |
| A double‐blind, randomized, controlled trial on N‐acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell … S Ataei, M Hadjibabaie, A Moslehi, M Taghizadeh‐Ghehi, A Ashouri, ... Hematological Oncology 33 (2), 67-74, 2015 | 17 | 2015 |
| Optimization of the Transwell® System for Assessing the Dissolution Behavior of Orally Inhaled Drug Products through In Vitro and In Silico Approaches E Amini, A Kurumaddali, S Bhagwat, SM Berger, G Hochhaus Pharmaceutics 13 (8), 1109, 2021 | 10 | 2021 |
| Chapter 9. Dissolution and drug release E Amini, G Hochhaus Inhaled Medicines, 225-266, 2021 | 8 | 2021 |
| Unraveling the Pulmonary Fate of Fluticasone and Friends: Meeting the Physiologic and Pharmacokinetic Challenges G Hochhaus, M Chen, J Shur, A Kurumaddali, U Schilling, Y Jiao, ... Respiratory Drug Delivery 2020 1 (2020), 139-146, 2020 | 5 | 2020 |
| Investigating acetazolamide effectiveness on CSF leak in adult patients after spinal surgery SB Kankam, E Amini, K Khoshnevisan, A Khoshnevisan Neurocirugía (English Edition) 33 (6), 293-299, 2022 | 4 | 2022 |
| Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays E Amini, SM Berger, U Schilling, Y Jiao, MJ Chen, S Bachhav, ... Molecular Pharmaceutics 20 (11), 5690-5700, 2023 | 2 | 2023 |
| Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics SK Drescher, Y Jiao, MJ Chen, A Kurumaddali, J Shao, E Amini, ... Pharmaceutical research 40 (5), 1177-1191, 2023 | 2 | 2023 |
| 505. Drug-drug interaction profiling of obeldesivir, a promising oral treatment for COVID-19 E Amini, M Shelton, A Raut, A Kwan, D Xiao, S Chen, S Madera, ... Open Forum Infectious Diseases 10 (Suppl 2), ofad500. 574, 2023 | 1 | 2023 |
| Advancing Bioequivalence Assessments of Orally Inhaled and Nasal Drug Products (OINDPs) Through In Vitro, In Vivo, and In Silico Approaches E Amini University of Florida, 2022 | 1 | 2022 |
| Dosing Cefazolin for Surgical Site Infection Prophylaxis in Adolescent Idiopathic Scoliosis Surgery: Intermittent Bolus or Continuous Infusion?—A Pilot Study Y Yu, FC Dooley, A Woods, A Gunnett, H Chandasana, E Amini, C Garvan, ... Journal of Clinical Medicine 13 (12), 3524, 2024 | | 2024 |
| Considerations for Conducting More Realistic Aerodynamic Particle Size Distribution Testing for Orally Inhaled Drug Products S Boc | | 2023 |
| Considerations and Challenges for Dissolution Testing of Orally Inhaled Drug Products (OIDPs) ER Bielski | | 2023 |
| Translational Approach to Establish Bioequivalence for Locally-acting Nasal Suspensions GH Elham Amini, Simon M Berger Clinical Pharmacology in Drug Development (Special Issue: 2022 Annual …, 2022 | | 2022 |
| Dissolution Testing for Supporting Bioequivalence Assessment of Nasal Suspensions SM Berger, E Amini, G Hochhaus Clinical Pharmacology in Drug Development (Special Issue: 2021 Annual …, 2021 | | 2021 |
| The Potential of Pharmacokinetic Studies to Facilitate Development of Generic Suspension-based Nasal Spray Products E Amini, SM Berger, J Shur, R Price, T Iley, JB Bulitta, G Hochhaus Clinical Pharmacology in Drug Development (Special Issue: 2021 Annual …, 2021 | | 2021 |
| Predictive Performance of a Novel In Vitro Dissolution Setup for Nasal Suspensions. Development and Validation of a Level A In Vitro‐In Vivo Correlation SM Berger, U Schilling, E Amini, R Cristofoletti, G Hochhaus Clinical Pharmacology in Drug Development (Special Issue: 2020 Annual …, 2020 | | 2020 |
